The acquisition brings three established small-molecule drug substance facilities into Siegfried’s global network
New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
C. P. Radhakrishnan urged graduates to uphold ethical standards and maintain a commitment to patient care
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
Policy symposium in Hyderabad focuses on life skills education and community?driven solutions
C-CAMP–Imperial College London partnership to boost biotech research, startup exchange, and translational innovation through a five-year collaboration
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
Subscribe To Our Newsletter & Stay Updated
